Evidence map›Paper›PMID 33083464›Full record

ArticleBioMed research international2020

TPPP3 Associated with Prognosis and Immune Infiltrates in Head and Neck Squamous Carcinoma.

Zheng Yang, Xiaohong Li, Jingyu Li, Qisheng Su, Yuling Qiu, Zunni Zhang, Liqian Zhang, Wuning Mo

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Integration of CD34Journal of translational medicine · 2022
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Zheng YangDepartment of Clinical Laboratory, First Affiliated Hospital Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China.
Xiaohong LiDepartment of Clinical Laboratory, First Affiliated Hospital Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China.
Jingyu LiDepartment of Otorhinolaryngology and Head and Neck Surgery, First Affiliated Hospital Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China.
Qisheng SuDepartment of Clinical Laboratory, First Affiliated Hospital Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China.
Yuling QiuDepartment of Clinical Laboratory, First Affiliated Hospital Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China.
Zunni ZhangDepartment of Clinical Laboratory, First Affiliated Hospital Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China.
Liqian ZhangDepartment of Clinical Laboratory, First Affiliated Hospital Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China.
Wuning MoDepartment of Clinical Laboratory, First Affiliated Hospital Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China.ORCID https://orcid.org/0000-0003-3074-3246
Guangxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tubulin polymerization promoting protein family member 3 (TPPP3) is a kind of protein that can mediate the dynamics and stability of microtubules. However, the correlations of TPPP3 between prognosis and immune infiltrates in different tumors are still unclear. The analysis of TPPP3 expression was performed via Oncomine and Gene Expression Profiling Interactive Analysis (GEPIA) website. We also used GEPIA to assess the impact of TPPPT3 on clinical outcomes. The related pathways involved in TPPP3 were analyzed by gene-set enrichment analysis (GSEA), and the correlation between TPPP3 and immune infiltration was studied by Tumor Immune Estimation Resource2.0 (TIMER 2.0). The TPPP3 expression was significantly reduced in head and neck squamous carcinoma (HNSC) compared to adjacent tissues. In addition, the low expression of TPPP3 in HNSC was significantly associated with prognosis. The pathways closely related to the low expression of TPPP3 are "Antigen Processing and Presentation," "Primary Immunodeficiency," and so on. The TPPP3 expression was negatively correlated with the level of CD8+ T cell, B cell, and myeloid dendritic cell infiltration in HNSC. The TPPP3 expression is closely related to multiple immunomarkers in CD8+ T cell and Myeloid dendritic cells. These data indicate that TPPP3 is associated with multiple cancers and involves multiple immune-related pathways, and TPPP3 is associated with immune infiltration levels. Besides, the TPPP3 expression may help regulate tumor-associated CD8 + T cells, DC cells in HNSC. We conclude TPPP3 can be considered as a biomarker for predicting head and neck squamous cell carcinoma prognosis and immune infiltration.

Indexed as

AdultBiomarkers, TumorCytoskeletal ProteinsFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticHead and Neck NeoplasmsHumansImmunohistochemistryKaplan-Meier EstimateLymphocytes, Tumor-InfiltratingMaleMiddle AgedPrognosisRNA, MessengerSquamous Cell Carcinoma of Head and NeckBiomarkers, TumorCytoskeletal ProteinsRNA, MessengerTPPP3 protein, human

Identifiers

PMID33083464
PMCPMC7563072
OpenAlexW3092393397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.